Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.7886 USD
−51.60 M USD
0.00 USD
43.41 M
About Mustang Bio, Inc.
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MBIO is 0.2051 USD — it has decreased by −1.35% in the past 24 hours. Watch Mustang Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mustang Bio, Inc. stocks are traded under the ticker MBIO.
MBIO stock has fallen by −14.54% compared to the previous week, the month change is a −40.03% fall, over the last year Mustang Bio, Inc. has showed a −87.02% decrease.
MBIO reached its all-time high on Aug 30, 2017 with the price of 200.2500 USD, and its all-time low was 0.1281 USD and was reached on Jun 10, 2024. View more price dynamics on MBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MBIO stock is 5.21% volatile and has beta coefficient of 1.98. Track Mustang Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Mustang Bio, Inc. there?
Today Mustang Bio, Inc. has the market capitalization of 9.80 M, it has decreased by −8.94% over the last week.
Yes, you can track Mustang Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Mustang Bio, Inc. is going to release the next earnings report on Mar 24, 2025. Keep track of upcoming events with our Earnings Calendar.
MBIO net income for the last quarter is −1.41 M USD, while the quarter before that showed −8.20 M USD of net income which accounts for 82.80% change. Track more Mustang Bio, Inc. financial stats to get the full picture.
No, MBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 80.00 employees. See our rating of the largest employees — is Mustang Bio, Inc. on this list?
Like other stocks, MBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mustang Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mustang Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mustang Bio, Inc. stock shows the sell signal. See more of Mustang Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.